Home › Trials › NCT02898987

Long-term monitoring of HIV-infected patients in France

Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients

Observational DatAids · NCT02898987

This study is collecting health information from over 30,000 people with HIV in France to see how their treatment and care change over time and how well their medications are working.

Quick facts

Study typeObservational
Enrollment30000 (estimated)
Ages18 Years and up
SexAll
SponsorDatAids Academic / other
Locations39 sites (Belfort and 38 other locations)
Trial IDNCT02898987 on ClinicalTrials.gov

What this trial studies

This observational study aims to collect and analyze clinical, laboratory, and therapeutic data from over 30,000 HIV-infected patients across 15 HIV centers in France. The study focuses on understanding the clinical practice and changes in the management of HIV and related co-infections over time. It evaluates the effectiveness of antiretroviral therapy (ART) and monitors the treatment outcomes for hepatitis C virus (HCV) among the cohort. Data is collected as part of routine care during scheduled outpatient visits, regardless of patients' CD4 cell count or ART status.

Who should consider this trial

Good fit: Ideal candidates for this study are HIV-1 infected patients of any age who are seeking care at participating HIV centers in France.

Not a fit: Patients under 18 years of age or those unable to provide written informed consent will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of HIV management and improve treatment strategies for patients.

How similar studies have performed: Other studies have successfully utilized similar cohort approaches to monitor HIV and its comorbidities, indicating a strong precedent for this methodology.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* HIV-1 infected patients regardless of CD4 cell count and antiretroviral therapy status

Exclusion Criteria:

* Patients under 18 years of age
* Patients without written informed consent

Where this trial is running

Belfort and 38 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions HIVHepatitis CComorbiditiesAIDS
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.